SCHEDULE: Janus Henderson Discloses 5.4% Stake in TYRA Biosciences

Janus Henderson Group plc has disclosed a 5.4% beneficial ownership stake in TYRA Biosciences, Inc., holding 2,856,290 common shares.

Summary

• Janus Henderson Group plc reported beneficial ownership of 2,856,290 shares of TYRA Biosciences, Inc. common stock.
• This ownership represents 5.4% of the outstanding common stock of TYRA Biosciences, Inc.
• Janus Henderson Group plc holds shared voting power and shared dispositive power over all 2,856,290 shares.
• The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing the control of TYRA Biosciences, Inc.

Sentiment

Score: 6

Explanation: A passive institutional stake of 5.4% is generally neutral to slightly positive, indicating confidence from a major asset manager without implying activist intent or immediate operational changes for the issuer.

Positives

• Janus Henderson Group plc, a significant institutional investor, holds a 5.4% stake in TYRA Biosciences, which can be interpreted as a vote of confidence in the company.

Future Outlook

This filing is a disclosure of current beneficial ownership and does not contain forward-looking statements or guidance from the issuer or the reporting person regarding the issuer's future performance.

Industry Context

This Schedule 13G filing reflects ongoing institutional investment activity within the biotechnology sector, where specialized firms like TYRA Biosciences often attract significant capital from asset managers like Janus Henderson.

Stakeholder Impact

• Shareholders: May view the significant institutional stake by Janus Henderson as a positive signal of confidence in TYRA Biosciences.

Key Dates

Keywords

TYRA Biosciences, Janus Henderson, Common Stock, Beneficial Ownership, SEC Filing, Schedule 13G, Institutional Investor, Biotechnology